Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Feb 17;5(1):49-52.
doi: 10.14744/bej.2020.65707. eCollection 2020.

Sterile Corneal Infiltrate Management After Corneal Crosslinking in Pediatric Keratoconus

Affiliations
Case Reports

Sterile Corneal Infiltrate Management After Corneal Crosslinking in Pediatric Keratoconus

Ayhan Saglik et al. Beyoglu Eye J. .

Abstract

A 6-year-old female was admitted to the ophthalmology department with a preliminary diagnosis of keratoconus. An accelerated cross-linking (CXL) protocol (9 mW/cm2 in 10 minutes) was performed on the right eye. On postoperative day 2, a slit-lamp examination revealed 2 corneal infiltrates with grade 3 haze. Since there was no growth in the cultivated cultures and no response to topical antibiotic treatment, the infiltrates were considered to be sterile, and topical 1% prednisolone drops were applied hourly. Despite topical steroid treatment of 1% prednisolone on postoperative day 5, no significant improvement was observed in the patient's symptoms and slit-lamp findings. Therefore, systemic 1 mg/kg prednisolone (total dose, 15 mg) was added to the treatment on postoperative day 5. One day after initiating the systemic steroid treatment, the infiltrates had shrunk, and the patient's complaints decreased. In patients with keratoconus who are under 10 years of age, the addition of a potent steroid regimen to the treatment may be essential in cases with suspected infiltrates after CXL treatment.

Keywords: Cross-linking; pediatric keratoconus; sterile infiltrate; steroid.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Scheimpflug topography maps of the right and left eyes before the crosslinking treatment.
Figure 2
Figure 2
Slit-lamp photograph of the patient after crosslinking treatment. (a) Postoperative day 2: Two infiltrates with grade 3 haze: one 1.5×1.5 mm in diameter at the 2 o’clock level and the other 0.5x0.5 mm in diameter at the corneal center. (b) Postoperative day 5: Despite topical steroid treatment with 1% prednisolone, no significant improvement was observed in the patient’s symptoms or slit-lamp findings. (c) Postoperative day 8: After systemic prednisolone treatment, the corneal infiltrates were completely resolved and scar formation developed. (d) Postoperative 6 months: Scar formation was present in the cornea center and at the 2 o’clock position.
Figure 3
Figure 3
Scheimpflug axial map comparison before the crosslinking treatment and the results at postoperative 6 months.

References

    1. Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998;42:297–319. - PubMed
    1. Jhanji V, Sharma N, Vajpayee RB. Management of keratoconus:current scenario. Br J Ophthalmol. 2011;95:1044–50. - PubMed
    1. Mukhtar S, Ambati BK. Pediatric keratoconus:a review of the literature. Int Ophthalmol. 2018;38:2257–66. - PMC - PubMed
    1. Gomes JA, Tan D, Rapuano CJ, Belin MW, Ambrósio R, Jr, Guell JL, et al. Global consensus on keratoconus and ectatic diseases. Cornea. 2015;34:359–69. - PubMed
    1. Krumeich JH, Daniel J, Knülle A. Live-epikeratophakia for keratoconus J Cataract Refract Surg. 1998;24:456–63. - PubMed

Publication types

LinkOut - more resources